يعرض 1 - 5 نتائج من 5 نتيجة بحث عن '"TOURMALINE-MM3"', وقت الاستعلام: 0.30s تنقيح النتائج
  1. 1
    Academic Journal

    المساهمون: Paiva B., Manrique I., Dimopoulos M.A., Gay F., Min C.-K., Zweegman S., Spicka I., Teipel R., Mateos M.-V., Giuliani N., Cavo M., Hopkins C.R., Fu W., Suryanarayan K., Vorog A., Li C., Wang B., Estevam J., Labotka R., Dash A.B.

    مصطلحات موضوعية: MRD, maintenance, prognostication, myeloma, TOURMALINE-MM3, TOURMALINE-MM4

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36130300; info:eu-repo/semantics/altIdentifier/wos/WOS:000943491100001; volume:141; issue:6; firstpage:579; lastpage:591; numberofpages:13; journal:BLOOD; https://hdl.handle.net/11585/957714; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85143285106; https://ashpublications.org/blood/article/141/6/579/486677/MRD-dynamics-during-maintenance-for-improved

  2. 2
    Academic Journal

    المساهمون: Goldschmidt H., Dimopoulos M.A., Rajkumar S.V., Weisel K.C., Moreau P., Chng W.-J., Mikala G., Cavo M., Ramasamy K., Suryanarayan K., Teng Z., Labotka R., Mateos M.V.

    مصطلحات موضوعية: TOURMALINE-MM3 study, maintenance therapy, ixazomib

    وصف الملف: STAMPA

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000528305800002; volume:34; issue:11; firstpage:3019; lastpage:3027; numberofpages:9; journal:LEUKEMIA; https://hdl.handle.net/11585/804171; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85083776145; https://www.nature.com/articles/s41375-020-0819-8

  3. 3
    Academic Journal

    المصدر: Schjesvold , F , Goldschmidt , H , Maisnar , V , Spicka , I , Abildgaard , N , Rowlings , P , Cain , L , Romanus , D , Suryanarayan , K , Rajkumar , V , Odom , D , Gnanasakthy , A & Dimopoulos , M 2020 , ' Quality of life is maintained with ixazomib maintenance in post-transplant newly diagnosed multiple myeloma : the TOURMALINE-MM3 trial ' , European journal of haematology , vol. 104 , no. 5 , pp. 443-458 . https://doi.org/10.1111/ejh.13379

    مصطلحات موضوعية: HRQoL, TOURMALINE-MM3, ixazomib, maintenance, placebo-controlled

    وصف الملف: application/pdf

  4. 4
    Academic Journal
  5. 5

    المساهمون: Takeda Pharmaceutical Company, Goldschmidt H., Dimopoulos M.A., Rajkumar S.V., Weisel K.C., Moreau P., Chng W.-J., Mikala G., Cavo M., Ramasamy K., Suryanarayan K., Teng Z., Labotka R., Mateos M.V.

    المصدر: Digital.CSIC. Repositorio Institucional del CSIC
    instname
    Leukemia

    وصف الملف: STAMPA